Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-16-013460
Filing Date
2016-05-16
Accepted
2016-05-16 16:24:56
Documents
49
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0316_immudyneinc.htm 10-Q 409627
2 CERTIFICATION f10q0316ex31i_immudyneinc.htm EX-31.1 10965
3 CERTIFICATION f10q0316ex32i_immudyneinc.htm EX-32.1 4987
  Complete submission text file 0001213900-16-013460.txt   2287587

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE immd-20160331.xml EX-101.INS 351179
5 XBRL SCHEMA FILE immd-20160331.xsd EX-101.SCH 27931
6 XBRL CALCULATION FILE immd-20160331_cal.xml EX-101.CAL 23965
7 XBRL DEFINITION FILE immd-20160331_def.xml EX-101.DEF 94571
8 XBRL LABEL FILE immd-20160331_lab.xml EX-101.LAB 242335
9 XBRL PRESENTATION FILE immd-20160331_pre.xml EX-101.PRE 173536
Mailing Address 50 SPRING MEADOW ROAD MT. KISCO NY 10549
Business Address 50 SPRING MEADOW ROAD MT. KISCO NY 10549 (914) 244-1777
Immudyne, Inc. (Filer) CIK: 0000948320 (see all company filings)

EIN.: 760238453 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-184487 | Film No.: 161654235
SIC: 2833 Medicinal Chemicals & Botanical Products